Your browser doesn't support javascript.
loading
Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center: Structure, Innovations, and Initial Outcomes.
Reams, R Renee; Odedina, Folakemi T; Carpten, John D; Redda, Kinfe; Stern, Mariana C; Krieger, Janice L; Aparicio, Jose; Hensel, Brooke; Askins, Nissa; Abreu, Andre; Adams, Angela; Agyare, Edward; Ali, Jamel; Allen, John M; Aló, Richard; Baezconde-Garbanati, Lourdes; Brant, Jason; Brown, Clyde P; Buxbaum, Sarah G; Cohen, Pinchas; Cozen, Wendy; Ezenwa, Miriam O; Falzarano, Sara; Fillingim, Roger B; Flores-Rozas, Hernan; Fredenburg, Kristianna M; George, Thomas; Han, Bo; Huang, Yong; Hughes Halbert, Chanita; Kiros, Gebre-Egziabher; Lamango, Nazarius S; Lee, Ji-Hyun; Lyon, Debra E; Mitchell, Duane A; Mochona, Bereket; Nieva, Jorge J; Offringa, Ite A; Okunieff, Paul; Parker, Alexander; Rhie, Suhn K; Richey, Joyce M; Rogers, Sherise C; Salhia, Bodour; Schmittgen, Thomas D; Segal, Richard; Setiawan, Veronica W; Smith, Ukamaka; Su, Li-Ming; Suther, Sandra.
Afiliação
  • Reams RR; College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida Agricultural and Mechanical University, Tallahassee, FL, USA.
  • Odedina FT; Mayo Clinic Comprehensive Cancer Center, Jacksonville, FL, USA.
  • Carpten JD; Department of Translational Genomics, University of Southern California, Los Angeles, CA, USA.
  • Redda K; College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida Agricultural and Mechanical University, Tallahassee, FL, USA.
  • Stern MC; Departments of Population and Public Health Sciences, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Krieger JL; Department of Advertising, University of Florida, Gainesville, FL, USA.
  • Aparicio J; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Hensel B; Department of Behavioral Nursing Science, University of Florida, Gainesville, FL, USA.
  • Askins N; Florida State University College of Medicine, Tallahassee, FL, USA.
  • Abreu A; Department of Urology, University of Southern California, Los Angeles, CA, USA.
  • Adams A; Department of Pharmaceutics, University of Florida, Gainesville, FL, USA.
  • Agyare E; College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida Agricultural and Mechanical University, Tallahassee, FL, USA.
  • Ali J; College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida Agricultural and Mechanical University, Tallahassee, FL, USA.
  • Allen JM; Department of Chemical and Biomedical Engineering, Florida State University, Tallahassee, FL, USA.
  • Aló R; Department of Pharmacotherapy & Translational Research, University of Florida, Orlando, FL, USA.
  • Baezconde-Garbanati L; College of Science and Technology, Florida Agricultural and Mechanical University, Tallahassee, FL, USA.
  • Brant J; Departments of Population and Public Health Sciences, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Brown CP; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
  • Buxbaum SG; College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida Agricultural and Mechanical University, Tallahassee, FL, USA.
  • Cohen P; College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida Agricultural and Mechanical University, Tallahassee, FL, USA.
  • Cozen W; University of Southern California Leonard Davis School of Gerontology, Los Angeles, CA, USA.
  • Ezenwa MO; Division of Hematology/Oncology, School of Medicine, University of California, Irvine, CA, USA.
  • Falzarano S; Department of Behavioral Nursing Science, University of Florida, Gainesville, FL, USA.
  • Fillingim RB; Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA.
  • Flores-Rozas H; Department of Community Dentistry and Behavioral Science, University of Florida, Gainesville, FL, USA.
  • Fredenburg KM; College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida Agricultural and Mechanical University, Tallahassee, FL, USA.
  • George T; Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA.
  • Han B; Department of Medicine in the College of Medicine, University of Florida, Gainesville, FL, USA.
  • Huang Y; Departments of Surgery, University of Southern California, Los Angeles, CA, USA.
  • Hughes Halbert C; Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL, USA.
  • Kiros GE; Departments of Population and Public Health Sciences, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Lamango NS; College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida Agricultural and Mechanical University, Tallahassee, FL, USA.
  • Lee JH; College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida Agricultural and Mechanical University, Tallahassee, FL, USA.
  • Lyon DE; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
  • Mitchell DA; Department of Behavioral Nursing Science, University of Florida, Gainesville, FL, USA.
  • Mochona B; Department of Neurosurgery, University of Florida, Gainesville, FL, USA.
  • Nieva JJ; Department of Chemistry, Florida Agricultural and Mechanical University, Tallahassee, FL USA.
  • Offringa IA; Department of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Okunieff P; Departments of Surgery, University of Southern California, Los Angeles, CA, USA.
  • Parker A; Department of Biochemistry and Molecular Medicine, University of Southern California, Los Angeles, CA, USA.
  • Rhie SK; Department of Radiation Oncology, University of Florida, Gainesville, FL, USA.
  • Richey JM; College of Medicine, University of Florida, Jacksonville, FL, USA.
  • Rogers SC; Department of Biochemistry and Molecular Medicine, University of Southern California, Los Angeles, CA, USA.
  • Salhia B; Department of Clinical Physiology and Neuroscience, University of Southern California, Los Angeles, CA, USA.
  • Schmittgen TD; Department of Medicine in the College of Medicine, University of Florida, Gainesville, FL, USA.
  • Segal R; Department of Translational Genomics, University of Southern California, Los Angeles, CA, USA.
  • Setiawan VW; Department of Pharmaceutics, University of Florida, Gainesville, FL, USA.
  • Smith U; Department of Pharmaceutical Outcome and Policy, University of Florida, Gainesville, FL, USA.
  • Su LM; Department of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Suther S; College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida Agricultural and Mechanical University, Tallahassee, FL, USA.
Cancer Control ; 30: 10732748231197878, 2023.
Article em En | MEDLINE | ID: mdl-37703814
ABSTRACT

INTRODUCTION:

The Florida-California Cancer Research, Education, and Engagement (CaRE2) Health Equity Center is a triad partnership committed to increasing institutional capacity for cancer disparity research, the diversity of the cancer workforce, and community empowerment. This article provides an overview of the structure, process innovations, and initial outcomes from the first 4 years of the CaRE2 triad partnership.

METHODS:

CaRE2 serves diverse populations in Florida and California using a "molecule to the community and back" model. We prioritize research on the complex intersection of biological, environmental, and social determinants health, working together with scientific and health disparities communities, sharing expertise across institutions, bidirectional training, and community outreach. Partnership progress and outcomes were assessed using mixed methods and four Program Steering Committee meetings.

RESULTS:

Research capacity was increased through development of a Living Repository of 81 cancer model systems from minority patients for novel cancer drug development. CaRE2 funded 15 scientific projects resulting in 38 publications. Workforce diversity entailed supporting 94 cancer trainees (92 URM) and 34 ESIs (32 URM) who coauthored 313 CaRE2-related publications and received 48 grants. Community empowerment was promoted via outreaching to more than 3000 individuals, training 145 community cancer advocates (including 28 Community Scientist Advocates), and publishing 10 community reports. CaRE2 members and trainees together have published 639 articles, received 61 grants, and 57 awards.

CONCLUSION:

The CaRE2 partnership has achieved its initial aims. Infrastructure for translational cancer research was expanded at one partner institution, and cancer disparities research was expanded at the two cancer centers.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Equidade em Saúde / Neoplasias Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Equidade em Saúde / Neoplasias Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article